Patents Assigned to Lexi Pharma, Inc.
  • COMPOSITIONS OF GALLIUM (III) COMPLEXES FOR ORAL ADMINISTRATION
    Publication number: 20180228734
    Abstract: The present invention relates to dosage forms of gallium complexes suitable for oral delivery and methods of preparation thereof. Such dosage forms are useful for the treatment of diseases, including, but not limited to, cancer.
    Type: Application
    Filed: February 9, 2018
    Publication date: August 16, 2018
    Applicant: Lexi Pharma Inc.
    Inventors: Rickey Roy RHINEBARGER, Gina G. STETSKO
  • METHOD TO PREVENT CANCER METASTASIS TO BONE
    Publication number: 20170326130
    Abstract: A method for treating osteoporosis and related methods are disclosed. The methods generally comprise administering to a patient in need of treatment an effective amount of tris(8-quinolinolato)gallium(III) or an analog thereof.
    Type: Application
    Filed: August 3, 2017
    Publication date: November 16, 2017
    Applicant: Lexi Pharma Inc.
    Inventor: Hooshmand SHESHBARADARAN
  • Method to prevent cancer metastasis to bone
    Patent number: 9725471
    Abstract: A method for treating osteoporosis and related methods are disclosed. The methods generally comprise administering to a patient in need of treatment an effective amount of tris(8-quinolinolato)gallium(III) or an analog thereof.
    Type: Grant
    Filed: August 2, 2013
    Date of Patent: August 8, 2017
    Assignee: Lexi Pharma, Inc.
    Inventor: Hooshmand Sheshbaradaran